Influenza Mutations, Pandemic Prompt FDA Proposal To Up-Classify Rapid Influenza Tests
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA’s experiences during the 2009 influenza virus epidemic, the potential lethality of influenza, and the propensity of the virus to mutate prompts a May 21 proposal that flu tests be regulated under class II with special controls, up from the current class 1 designation.
You may also be interested in...
White House To Deliver 25 Million Face Masks To Low-Income Americans
The White House will be spending $86m to provide tens of millions of coronavirus masks to poorer American households.
HHS Secretary Nominee Becerra Commits To Telehealth Expansion, Procedure Price Transparency
At two recent confirmation hearings, HHS secretary nominee Xavier Becerra promised Senators he would help expand telehealth and procedure price transparency.
US Medicare Agency Makes It Easier For Texas Suppliers To Replace DME Lost To Winter Storms
Durable medical equipment suppliers get temporary HHS and CMS waivers to help Texas Medicare and Medicaid beneficiaries due to the state’s winter storm.